ylliX - Online Advertising Network
Company Ticker News

Expert opinion: ‘Bristol-Myers is a buy’

Expert opinion: ‘Bristol-Myers is a buy'

<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>

Shares of Bristol-Myers Squibb Co (NYSE: BMY) are up more than 3.0% on Monday after the pharmaceutical company said it will repurchase $5.0 billion worth of its stock in Q1. CEO says business development is a priority Interestingly, however, CEO Giovanni Caforio says business development is a priority for Bristol-Myers.

...read full article on Invezz

ylliX - Online Advertising Network